The operational challenges of making patient-specific cell therapies require careful consideration. Choosing the manufacturing model that fits the healthcare infrastructure, the logistical requirements, and the market environment of the specific project is key. The post No One-Size-Fits-All Solution for Autologous Cell Therapy Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News .